fda - Search News

News

FDA approves Gardenia blue

UPI on MSN · 8h

FDA adds new blue food dye from gardenia fruit

The U.S. Food and Drug Administration on Monday approved the use of a new blue color additive from the gardenia fruit the fourth coloring from natural sources added in the last two months.

FDA approves natural color additive gardenia blue, asks for quicker phase-out of Red No. 3

The FDA has approved the natural color additive gardenia (genipin) blue for use in various foods and drinks at “levels consistent with good manufacturing practice,” according to an agency press release.

Food Dive · 11h

FDA approves natural blue color, urges accelerated phaseout of synthetic red dye

The White House asked companies to remove Red No. 3, an artificial color in candy and cereal, sooner than the 2027 deadline put in place by the Biden administration.

2don MSN

FDA Issues Risk Warning as Apples Recalled in Four States

A recall of thousands of cases of fruits and vegetables has been issued due to potential fluid contamination—the ...

BioPharma Dive15h

FDA rejects Ultragenyx gene therapy over manufacturing concerns

While the CRL derails a near-term clearance, one analyst described the rejection as more of “a speed bump to approval, rather ...

FoodNavigator-USA20h

FDA urges infant and children’s food brands to improve recall communications under Operation Stork Speed

FDA is urging manufacturers of infant formula, baby food and children’s nutrition products to sharpen their recall ...

1don MSN

FDA issues highest risk warning after mushrooms recalled nationwide

The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...

17hon MSN

GSK seeks FDA nod for expanded use of RSV vaccine in adults

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

FDA declines to approve Ultragenyx gene therapy

In his first 100 days as commissioner of the Food and Drug Administration, Marty Makary has made a handful of splashy ...

19h

Capricor Therapeutics: Buying Opportunity Following FDA's Complete Response Letter

Capricor Therapeutics's dip caused by the CRL is a buying opportunity considering the readout of HOPE-3 within 2-3 months.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results